Levomecor

Beijing Levomecor Biotechnology is a Chinese medical technology company specializing in the development and manufacture of in-vitro diagnostic (IVD) systems and point-of-care testing (POCT) solutions. The company primarily focuses on cardiovascular health, providing high-sensitivity rapid assay kits for cardiac biomarkers such as Troponin I, Myoglobin, and NT-proBNP. Levomecor's diagnostic platforms utilize advanced immunochromatography technology to deliver precise results, aiding in the early diagnosis and management of conditions like acute myocardial infarction and heart failure. Founded in 2011, the company provides integrated diagnostic tools for clinical laboratories and emergency departments to improve metabolic and cardiac patient outcomes.